StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.44+0.03 (+2.13%)

Close on Nov 17, 2026Market cap $120.11MP/E –Yield –

Pyxis Oncology total assets

Total assets on the balance sheet at the end of each period.

Pyxis Oncology's total assets was $54.92M at Jun 30, 2026. For fiscal 2025 it was $91.52M, down 41.8% from the year before. The highest annual figure on record is $280.02M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$91.52M-41.8%
FY2024Dec 31, 2024$157.18M-9.5%
FY2023Dec 31, 2023$173.73M-17.8%
FY2022Dec 31, 2022$211.38M-24.5%
FY2021Dec 31, 2021$280.02M+2658.6%
FY2020Dec 31, 2020$10.15M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$54.92M-55.4%
Q1 FY2026Mar 31, 2026$64.30M-52.7%
Q4 FY2025Dec 31, 2025$91.52M-41.8%
Q3 FY2025Sep 30, 2025$105.60M-45.9%
Q2 FY2025Jun 30, 2025$123.22M-40.9%
Q1 FY2025Mar 31, 2025$135.87M-38.3%
Q4 FY2024Dec 31, 2024$157.18M-9.5%
Q3 FY2024Sep 30, 2024$195.31M+4.6%
Q2 FY2024Jun 30, 2024$208.39M+18.9%
Q1 FY2024Mar 31, 2024$220.22M+20.5%
Q4 FY2023Dec 31, 2023$173.73M-17.8%
Q3 FY2023Sep 30, 2023$186.69M-16.6%
Q2 FY2023Jun 30, 2023$175.23M-27.8%
Q1 FY2023Mar 31, 2023$182.80M-27.7%
Q4 FY2022Dec 31, 2022$211.38M-24.5%
Q3 FY2022Sep 30, 2022$223.90M+60.5%
Q2 FY2022Jun 30, 2022$242.56M+2289.5%
Q1 FY2022Mar 31, 2022$252.70M–
Q4 FY2021Dec 31, 2021$280.02M–
Q3 FY2021Sep 30, 2021$139.49M–
Q4 FY2020Dec 31, 2020$10.15M–

More Pyxis Oncology figures

See a number that looks wrong?